Gabrielle Heilek

1.1k total citations
32 papers, 798 citations indexed

About

Gabrielle Heilek is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Gabrielle Heilek has authored 32 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Virology, 13 papers in Infectious Diseases and 10 papers in Epidemiology. Recurrent topics in Gabrielle Heilek's work include HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (11 papers) and Immune Cell Function and Interaction (7 papers). Gabrielle Heilek is often cited by papers focused on HIV Research and Treatment (14 papers), HIV/AIDS drug development and treatment (11 papers) and Immune Cell Function and Interaction (7 papers). Gabrielle Heilek collaborates with scholars based in United States, Germany and Switzerland. Gabrielle Heilek's co-authors include Brian Rhees, John M. Burke, Amy J. Sehnert, Richard P. Rava, Eileen de Feo, M G Peterson, Andreas Jekle, Changhua Ji, Bryan Cobb and Klaus Klumpp and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Gabrielle Heilek

31 papers receiving 774 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gabrielle Heilek United States 15 321 222 199 182 177 32 798
Mei‐ying W. Yu United States 14 244 0.8× 47 0.2× 51 0.3× 354 1.9× 72 0.4× 24 729
William B. Mahony United States 12 293 0.9× 77 0.3× 198 1.0× 156 0.9× 176 1.0× 17 588
Tsuguhiro Kaneda Japan 14 275 0.9× 49 0.2× 184 0.9× 85 0.5× 210 1.2× 35 568
Wendy Snowden United Kingdom 16 367 1.1× 33 0.1× 269 1.4× 353 1.9× 96 0.5× 24 786
Lisa Ross United States 21 1.0k 3.1× 33 0.1× 810 4.1× 263 1.4× 272 1.5× 69 1.6k
Ronna E. Dornsife United States 16 613 1.9× 27 0.1× 426 2.1× 559 3.1× 412 2.3× 25 1.4k
Carey Hwang United States 20 802 2.5× 29 0.1× 665 3.3× 396 2.2× 188 1.1× 49 1.2k
T Shirasaka United States 13 1.1k 3.3× 32 0.1× 967 4.9× 233 1.3× 260 1.5× 17 1.3k
Nuanjun Wichukchinda Thailand 19 362 1.1× 71 0.3× 195 1.0× 248 1.4× 126 0.7× 45 943
Hiromi Ogata Japan 11 384 1.2× 12 0.1× 384 1.9× 102 0.6× 291 1.6× 22 902

Countries citing papers authored by Gabrielle Heilek

Since Specialization
Citations

This map shows the geographic impact of Gabrielle Heilek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabrielle Heilek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabrielle Heilek more than expected).

Fields of papers citing papers by Gabrielle Heilek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabrielle Heilek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabrielle Heilek. The network helps show where Gabrielle Heilek may publish in the future.

Co-authorship network of co-authors of Gabrielle Heilek

This figure shows the co-authorship network connecting the top 25 collaborators of Gabrielle Heilek. A scholar is included among the top collaborators of Gabrielle Heilek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabrielle Heilek. Gabrielle Heilek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Jessica, Nicole C. Charland, Ebad Ahmed, et al.. (2025). A Novel Method to Estimate Donor-Derived Cell-Free DNA in Pregnant Kidney Transplant Recipients: A Proof-of-Concept Study. Transplantation Proceedings. 57(5). 706–712.
2.
Patel, Rajesh, Hans-Peter Adams, Xueping Qu, et al.. (2022). Detection of minimal residual disease (MRD) in colorectal cancer (CRC) patients UICC stage II/III by ultra-deep sequencing of cfDNA from post-surgery plasma.. Journal of Clinical Oncology. 40(4_suppl). 26–26. 2 indexed citations
3.
Feldkamp, Mirjam, et al.. (2021). Innovative Tumor Tissue Dissection Tool for Molecular Oncology Diagnostics. Journal of Molecular Diagnostics. 23(4). 399–406. 6 indexed citations
4.
Tan, Le Van, Guy Thwaites, Graham Cooke, et al.. (2019). Differential prevalence and geographic distribution of hepatitis C virus genotypes in acute and chronic hepatitis C patients in Vietnam. PLoS ONE. 14(3). e0212734–e0212734. 12 indexed citations
5.
Yao, Joseph D., et al.. (2018). Diagnosis and monitoring of HCV infection using the cobas ® HCV test for use on the cobas ® 6800/8800 systems. Journal of Clinical Virology. 102. 63–69. 16 indexed citations
6.
Kessler, Harald H., Bryan Cobb, Heiner Wedemeyer, et al.. (2015). Evaluation of the COBAS® AmpliPrep/COBAS® TaqMan® HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study. Journal of Clinical Virology. 67. 67–72. 16 indexed citations
7.
8.
Lemoine, Rémy C., Ann Petersen, Jutta Wanner, et al.. (2010). Evaluation of a 3-amino-8-azabicyclo[3.2.1]octane replacement in the CCR5 antagonist maraviroc. Bioorganic & Medicinal Chemistry Letters. 20(5). 1674–1676. 14 indexed citations
9.
Javanbakht, Hassan, Roger G. Ptak, Eric P. F. Chow, et al.. (2010). In vitro resistance development for RO-0335, a novel diphenylether nonnucleoside reverse transcriptase inhibitor. Antiviral Research. 86(2). 212–219. 7 indexed citations
10.
Lemoine, Rémy C., Ann Petersen, Andreas Jekle, et al.. (2010). Exploration of a new series of CCR5 antagonists: Multi-dimensional optimization of a sub-series containing N-substituted pyrazoles. Bioorganic & Medicinal Chemistry Letters. 20(16). 4753–4756. 3 indexed citations
11.
Kertesz, D, Minmin Yang, Zhanguo Wang, et al.. (2010). Discovery of piperidin-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Benzyl derivatives with broad potency against resistant mutant viruses. Bioorganic & Medicinal Chemistry Letters. 20(14). 4215–4218. 67 indexed citations
12.
Padilla, Fernando, Surya Sankuratri, Changhua Ji, et al.. (2010). Synthesis, SAR and evaluation of [1,4′]-bipiperidinyl-4-yl-imidazolidin-2-one derivatives as novel CCR5 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(11). 3219–3222. 8 indexed citations
13.
Lemoine, Rémy C., Ann Petersen, Lijing Chen, et al.. (2010). Evaluation of a 4-aminopiperidine replacement in several series of CCR5 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(6). 1830–1833. 9 indexed citations
14.
Tang, Guozhi, D Kertesz, Minmin Yang, et al.. (2010). Exploration of piperidine-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Phenyl derivatives with broad potency against resistant mutant viruses. Bioorganic & Medicinal Chemistry Letters. 20(20). 6020–6023. 31 indexed citations
15.
Wanner, Jutta, Lijing Chen, Rémy C. Lemoine, et al.. (2010). Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series. Bioorganic & Medicinal Chemistry Letters. 20(22). 6802–6807. 2 indexed citations
16.
Jekle, Andreas, Erhard Kopetzki, Changhua Ji, et al.. (2009). CD4-BFFI: A novel, bifunctional HIV-1 entry inhibitor with high and broad antiviral potency. Antiviral Research. 83(3). 257–266. 11 indexed citations
17.
Kopetzki, Erhard, Andreas Jekle, Changhua Ji, et al.. (2008). Closing two doors of viral entry: Intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1. Virology Journal. 5(1). 56–56. 22 indexed citations
18.
Ji, Changhua, Erhard Kopetzki, Andreas Jekle, et al.. (2008). CD4-anchoring HIV-1 Fusion Inhibitor with Enhanced Potency and in Vivo Stability. Journal of Biological Chemistry. 284(8). 5175–5185. 21 indexed citations
19.
Sweeney, Zachary K., Sahaja Acharya, Andrew J. Briggs, et al.. (2008). Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptase. Bioorganic & Medicinal Chemistry Letters. 18(15). 4348–4351. 23 indexed citations
20.
Heilek, Gabrielle & M G Peterson. (1997). A point mutation abolishes the helicase but not the nucleoside triphosphatase activity of hepatitis C virus NS3 protein. Journal of Virology. 71(8). 6264–6266. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mei‐ying W. Yu Breakdown of academic impact, for papers by William B. Mahony Breakdown of academic impact, for papers by Tsuguhiro Kaneda Breakdown of academic impact, for papers by Wendy Snowden Breakdown of academic impact, for papers by Lisa Ross Breakdown of academic impact, for papers by Ronna E. Dornsife Breakdown of academic impact, for papers by Carey Hwang Breakdown of academic impact, for papers by T Shirasaka Breakdown of academic impact, for papers by Nuanjun Wichukchinda Breakdown of academic impact, for papers by Hiromi Ogata
Rankless by CCL
2026